Purdue Pharma LP drugs
5 results
Butrans (buprenorphine)
(buprenorphine)Purdue Pharma LP
Usage: BUTRANS is indicated for the management of severe and persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not suitable for as-needed use and should be reserved for cases where other treatments are ineffective or intolerable due to the risks of addiction and overdose.
Hysingla er (hydrocodone bitartrate)
(hydrocodone bitartrate)Purdue Pharma LP
Usage: HYSINGLA ER is indicated for managing severe, persistent pain requiring long-term opioid treatment when alternative options are inadequate. It is not for as-needed use and should be reserved for patients who cannot tolerate or achieve sufficient pain relief from other treatments due to the risks of opioid use.
Ms contin (morphine sulfate)
(morphine sulfate)Purdue Pharma LP
Usage: MS CONTIN is indicated for managing severe pain requiring long-term, around-the-clock opioid treatment when alternative options are inadequate. It is not intended for as-needed use and should be prescribed cautiously due to risks of addiction, abuse, and overdose associated with opioids.
Oxycontin (oxycodone hydrochloride)
(oxycodone hydrochloride)Purdue Pharma LP
Usage: OXYCONTIN is indicated for severe, persistent pain management in adults and opioid-tolerant pediatric patients aged 11 and older, when alternative treatments are inadequate. It is not intended for as-needed use and carries risks of addiction, abuse, and misuse.
Targiniq (oxycodone hydrochloride/naloxone hydrochloride)
(Oxycodone hydrochloride/naloxone hydrochloride)Purdue Pharma LP
Usage: TARGINIQ ER is indicated for the management of severe pain requiring long-term, around-the-clock opioid treatment when alternative options are inadequate. It is not suitable for as-needed analgesia and should be reserved for patients with insufficient pain relief from other treatments due to addiction and overdose risks.